:: 피부과학의 선도기업, 네오팜 ::
  • 회사소개
  • 브랜드소개
  • 연구개발
  • 홍보센터
  • 채용정보
  • 투자정보
  • 네오팜 소개 글로벌 네트워크 오시는 길
  • 아토팜 아토팜 제로이드 더마비 에이토솔루션
  • 연구소이야기 Skin Care
  • 네오팜 언론기사
  • 인재상 복리후생 지원방법
  • 주가정보 공시정보 재무정보 자료실
닫기

CRO Biz Model Home >  연구개발 > 신약개발

section process express standard advanced
Advanced Target(RTK, GPCR, Ligand, Cytokine etc.) consulting
Antigen preparation (option)
Optimization of ELISA conditions
Biopanning (Ag specific scFv)
Selection by ELISA
Kd determination by Biacore (option) (pET vector using)
Sorting by DNA sequencing (option)
Supplied materials (Selected phagemids)
Price negotiable
Section ll
lgG conversion &
Transient culture
Conversion into human lgG
Mix match optimization (option)
Transient expression
Selection by ELISA
Kd determination by Biacore
Supplied materials (Purified full lgG)
Price negotiable
Section Ⅲ
Lead
optimization &
Cell line
construction
Tissue Cross Reactivity (TCR)
Cell based functional assay
Affinity maturation
Cell line construction
Production and purification
Animal study (option)
Supplied materials (Purified full lgG & cloned cell line)
Price negotiable
All optional items containing sample preparation and functional study are available